StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ultragenyx Pharmaceutical Inc.
NasdaqGS:RARE
Sector
Industries
Location
Market Cap
USD 3.77 B
Share Price
USD 39.91
Avg Daily Volume
934,614
Change (1 day)
1.14%
Change (1 year)
-0.75%
Change (YTD)
-5.13%
Ultragenyx Pharmaceutical Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -413.04 M
Ultragenyx Pharmaceutical Inc. Free Cash Flow is USD -413.04 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -24.02% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Ultragenyx Pharmaceutical Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -543.61 M, a 2.80% change year over year.
-
Ultragenyx Pharmaceutical Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -528.78 M, a 27.19% change year over year.
-
Ultragenyx Pharmaceutical Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -415.73 M, a 71.34% change year over year.
-
Ultragenyx Pharmaceutical Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -242.64 M, a -36.25% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Siemens Healthineers AG
USD 55.17
SHL.DE
-0.78
-1.39%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Siemens Healthineers AG
USD 55.17
SHL.DE
-0.78
-1.39%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%